Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel radioimmunotherapy and ...

On Tuesday, January 7, the FDA announced it would now be requiring GSK and Pfizer’s RSV vaccines to hold warnings of a risk ...

As for GBS itself, this neurological ailment can be severe, attacking nerves and warranting hospitalisation for weeks or ...

In a recent “Dear Veterinarian” letter, the FDA alerted veterinarians of adverse events in dogs treated with bedinvetmab ...

In the PET trial, RAP-219 achieved and exceeded target receptor occupancy, increasing support for the dosing regimen utilized in the ongoing ...

A pain-relieving medication might be safer for seniors than first thought.A new study published Jan. 7 in the Annals ...

In a personal essay for PEOPLE, TikTok star Eldiara Doucette opens up about her recurring soft tissue cancer, losing her ...

As we observe Glaucoma Awareness Month this January, it is essential to recognize the significance of regular eye checkups, ...

A newly published study from Aarhus University Hospital shows that fecal microbiota transplantation (FMT)—a method where gut ...

That can create a “potential snowball effect” of bias that further amplifies human behavior, one researcher said in a press release, partly because the authors said people seem to believe AI is more ...

A top NYC weight-loss doctor shared the surprising skin complication that he’s encountered in patients using GLP-1 drugs like ...

Nalu Medical, Inc. ("Nalu"), a leader in peripheral nerve stimulation, announced the publication of a study in Pain Management journal showing that the use of Nalu PNS therapy in chronic pain patients ...